The discussion highlights the high costs associated with continuous glucose monitors, driven by regulatory challenges and the need for compliance as medical devices. The convenience of a smartwatch that could replace finger pricking and offer continuous data is deemed worth the investment, especially considering the ongoing expenses of current monitors and their consumables.
